0000950170-23-052934.txt : 20231011
0000950170-23-052934.hdr.sgml : 20231011
20231011170032
ACCESSION NUMBER: 0000950170-23-052934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20231011
DATE AS OF CHANGE: 20231011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CUMMING JOHN W
CENTRAL INDEX KEY: 0001181189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 231321241
MAIL ADDRESS:
STREET 1: 35 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2023-09-15
0001492674
T2 Biosystems, Inc.
TTOO
0001181189
CUMMING JOHN W
101 HARTWELL AVE
LEXINGTON
MA
02421
true
false
false
false
false
Common Stock
2023-09-15
4
M
false
2600
A
5256
D
Restricted Stock Units
2023-09-15
4
M
false
2600
0.00
D
Common Stock
2600
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On October 11, 2022, the reporting person was granted 2,600 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.
/s/ John Sprague, Attorney-in-Fact
2023-10-11